ClinicalTrials.Veeva

Menu

The Precision and Arm-to-Arm Variation of Mechanomyography and Acceleromyography for Monitoring of Neuromuscular Block

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Neuromuscular Blockade

Treatments

Device: TOF-Watch SX (neuromuscular monitor)

Study type

Observational

Funder types

Other

Identifiers

NCT00472121
MMG-MMG

Details and patient eligibility

About

The purpose of the study is the examine the precision of acceleromyography and mechanomyography during recovery from a neuromuscular blocking agent and to examine whether there is any difference in monitoring block at the dominant or non-dominant arm. Our hypothesis is that there is no significant difference in neither the precision nor the level of block in the contralateral arms.

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA I-III
  • General anesthesia >1 hour
  • Surgery in supine position w. possibility of monitoring the neuromuscular block at both arms (n. ulnaris stimulation/thumb response)
  • Written informed content

Exclusion criteria

  • Neuromuscular disorders, hepatic and renal dysfunction
  • Medication expected to interfere with the neuromuscular blocking agent
  • Allergy to any medication used during anaesthesia
  • Body weight less or exceeding 20% of ideal body weight
  • Pregnancy or breastfeeding

Trial design

0 participants in 2 patient groups

1: AMG
Treatment:
Device: TOF-Watch SX (neuromuscular monitor)
2: MMG
Treatment:
Device: TOF-Watch SX (neuromuscular monitor)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems